Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ULK1 | O75385 | 1/20 | 0.63 |
| ▸ | PAK4 | O96013 | 9/20 | 0.62 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.60 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3582538 | 0.93 | ULK1 (0.66) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3579380 | 0.90 | ULK1 (0.62) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3579029 | 0.89 | PIN1 (0.60) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3590277 | 0.89 | NPY5R (0.67) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3583297 | 0.89 | ULK1 (0.61) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3585093 | 0.88 | ULK1 (0.60) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3581297 | 0.87 | ULK1 (0.59) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3577758 | 0.87 | ULK1 (0.59) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3577599 | 0.86 | KDR (0.62) | ULK1PAK4TGFBR1ROCK2NPY5R | |
| SCHEMBL3575384 | 0.85 | SMO (0.57) | ULK1PAK4TGFBR1ROCK2NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1370553-B1 | RHO-KINASE INHIBITORS | BAYER AG (US) | 2006-05-10 | — | — | EP | claimed |
| EP-1370553-B1 | RHO-KINASE INHIBITORS | BAYER AG (US) | 2006-05-10 | — | — | EP | disclosed |